Tenet Healthcare (NYSE:THC) Price Target Raised to $342.00

Tenet Healthcare (NYSE:THC) had its price objective increased by Leerink Partners from $309.00 to $342.00 in a report published on Monday,Benzinga reports. They currently have an outperform rating on the stock.

Other equities research analysts have also issued reports about the company. Stephens restated an “overweight” rating and set a $285.00 price target on shares of Tenet Healthcare in a research report on Monday, July 27th. Wall Street Zen upgraded Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 17th. Weiss Ratings raised Tenet Healthcare from a “buy (b-)” rating to a “buy (b)” rating in a research note on Thursday, October 8th. Mizuho set a $305.00 target price on Tenet Healthcare in a report on Monday. Finally, UBS Group increased their target price on Tenet Healthcare from $288.00 to $308.00 and gave the stock a “buy” rating in a report on Monday, July 27th. Twenty equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Tenet Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $293.48.

Tenet Healthcare Trading Up 9.2%

Shares of THC stock opened at $291.26 on Monday. The company has a market capitalization of $23.18 billion, a P/E ratio of 8.45, a P/E/G ratio of 1.43 and a beta of 1.20. Tenet Healthcare has a 12-month low of $157.58 and a 12-month high of $294.11. The company has a quick ratio of 1.52, a current ratio of 1.58 and a debt-to-equity ratio of 1.76. The firm has a 50-day moving average price of $264.75 and a 200 day moving average price of $221.49.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Thursday, October 29th. The company reported $6.64 earnings per share for the quarter, topping the consensus estimate of $4.68 by $1.96. Tenet Healthcare had a net margin of 13.09% and a return on equity of 28.22%. The company had revenue of $6.28 billion during the quarter, compared to analyst estimates of $5.49 billion. During the same quarter last year, the business posted $3.70 earnings per share. The company’s revenue was up 6.5% on a year-over-year basis. Research analysts forecast that Tenet Healthcare will post 22.32 earnings per share for the current fiscal year.

Insider Activity at Tenet Healthcare

In other news, Director J. Robert Kerrey sold 12,010 shares of the company’s stock in a transaction on Monday, September 14th. The stock was sold at an average price of $263.72, for a total transaction of $3,167,277.20. Following the transaction, the director owned 4,794 shares of the company’s stock, valued at $1,264,273.68. This represents a 71.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Richard Mark sold 10,000 shares of the firm’s stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $263.42, for a total value of $2,634,200.00. Following the completion of the transaction, the director owned 25,121 shares in the company, valued at approximately $6,617,373.82. This represents a 28.47% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 100,962 shares of company stock valued at $27,440,309 over the last quarter. 0.97% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Tenet Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of the business. Lido Advisors LLC bought a new position in shares of Tenet Healthcare in the third quarter valued at $666,000. M&G PLC bought a new stake in Tenet Healthcare during the third quarter worth $14,609,000. AlphaCore Capital LLC bought a new stake in Tenet Healthcare during the third quarter worth $244,000. Leuthold Group LLC lifted its stake in Tenet Healthcare by 8.6% in the third quarter. Leuthold Group LLC now owns 34,405 shares of the company’s stock valued at $8,793,000 after acquiring an additional 2,730 shares during the last quarter. Finally, Retirement Systems of Alabama lifted its stake in Tenet Healthcare by 2.6% in the third quarter. Retirement Systems of Alabama now owns 153,307 shares of the company’s stock valued at $39,179,000 after acquiring an additional 3,860 shares during the last quarter. 95.44% of the stock is owned by institutional investors.

More Tenet Healthcare News

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet reported quarterly EPS of $6.64, topping the $4.68 consensus estimate, and revenue of $6.28 billion versus expectations of $5.49 billion. Revenue increased 6.5% year over year. Tenet Healthcare stock after Q3: 2026 EBITDA outlook raised
• Positive Sentiment: Management raised its 2026 EBITDA outlook, adding to investor optimism about the company’s earnings prospects. Tenet Healthcare stock after Q3: 2026 EBITDA outlook raised
• Positive Sentiment: Barclays raised its price target to $297 from $271 and maintained an “overweight” rating. Truist reaffirmed “buy” and raised its target to $305 from $290, while KeyCorp lifted its target to $300 from $270 and retained “overweight” coverage.
• Positive Sentiment: Wells Fargo, Leerink Partners, and Royal Bank of Canada were also cited as expecting further appreciation in THC shares. Read More., Read More., Read More.
• Neutral Sentiment: Zacks noted increased investor attention to Tenet, but its article focused on factors to consider rather than announcing a specific rating or forecast change. Tenet Healthcare Is a Trending Stock

Tenet Healthcare Company Profile

Tenet Healthcare Corp. (NYSE: THC) is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.

Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.